Prognostic Value of Stress CMR Perfusion Imaging in Patients With Reduced Left Ventricular Function

Yin Ge; Panagiotis Antiochos; Kevin Steel; Scott Bingham; Shuaib Abdullah; Yi Yun Chen; J. Ronald Mikolich; Andrew E. Arai; W. Patricia Bandettini; Sujata M. Shanbhag; Amit R. Patel; Afshin Farzaneh-Far; John F. Heitner; Chetan Shenoy; Steve W. Leung; Jorge A. Gonzalez; Dipan J. Shah; Subha V. Raman; Victor A. Ferrari; Jeanette Schulz-Menger; Matthias Stuber; Orlando P. Simonetti; Raymond Y. Kwong

doi:10.1016/j.jcmg.2020.05.034

Prognostic Value of Stress CMR Perfusion Imaging in Patients With Reduced Left Ventricular Function

Yin Ge
, Panagiotis Antiochos
, Kevin Steel
, Scott Bingham
, Shuaib Abdullah
, Yi Yun Chen
, J. Ronald Mikolich
, Andrew E. Arai
, W. Patricia Bandettini
, Sujata M. Shanbhag
, Amit R. Patel
, Afshin Farzaneh-Far
, John F. Heitner
, Chetan Shenoy
, Steve W. Leung
, Jorge A. Gonzalez
, Dipan J. Shah
, Subha V. Raman
, Victor A. Ferrari
, Jeanette Schulz-Menger

Matthias Stuber, Orlando P. Simonetti, Raymond Y. Kwong

Producción científica: Article › revisión exhaustiva

33 Citas (Scopus)

Resumen

Objectives: The aim of this study was to investigate the prognostic value of stress cardiac magnetic resonance imaging (CMR) in patients with reduced left ventricular (LV) systolic function. Background: Patients with ischemic cardiomyopathy are at risk from both myocardial ischemia and heart failure. Invasive testing is often used as the first-line investigation, and there is limited evidence as to whether stress testing can effectively provide risk stratification. Methods: In this substudy of a multicenter registry from 13 U.S. centers, patients with reduced LV ejection fraction (<50%), referred for stress CMR for suspected myocardial ischemia, were included. The primary outcome was cardiovascular death or nonfatal myocardial infarction. The secondary outcome was a composite of cardiovascular death, nonfatal myocardial infarction, hospitalization for unstable angina or congestive heart failure, and unplanned late coronary artery bypass graft surgery. Results: Among 582 patients (mean age 62 ± 12 years, 34% women), 40% had a history of congestive heart failure, and the median LV ejection fraction was 39% (interquartile range: 28% to 45%). At median follow-up of 5.0 years, 97 patients had experienced the primary outcome, and 182 patients had experienced the secondary outcome. Patients with no CMR evidence of ischemia or late gadolinium enhancement (LGE) experienced an annual primary outcome event rate of 1.1%. The presence of ischemia, LGE, or both was associated with higher event rates. In a multivariate model adjusted for clinical covariates, ischemia and LGE were independent predictors of the primary (hazard ratio [HR]: 2.63; 95% confidence interval [CI]: 1.68 to 4.14; p < 0.001; and HR: 1.86; 95% CI: 1.05 to 3.29; p = 0.03) and secondary (HR: 2.14; 95% CI: 1.55 to 2.95; p < 0.001; and HR 1.70; 95% CI: 1.16 to 2.49; p = 0.007) outcomes. The addition of ischemia and LGE led to improved model discrimination for the primary outcome (change in C statistic from 0.715 to 0.765; p = 0.02). The presence and extent of ischemia were associated with higher rates of use of downstream coronary angiography, revascularization, and cost of care spent on ischemia testing. Conclusions: Stress CMR was effective in risk-stratifying patients with reduced LV ejection fractions.

Idioma original	English
Páginas (desde-hasta)	2132-2145
Número de páginas	14
Publicación	JACC: Cardiovascular Imaging
Volumen	13
N.º	10
DOI	https://doi.org/10.1016/j.jcmg.2020.05.034
Estado	Published - oct 2020

Nota bibliográfica

Publisher Copyright:
© 2020 American College of Cardiology Foundation

Financiación

The SPINS registry was funded by the Society for Cardiovascular Magnetic Resonance, using a research grant jointly sponsored by Siemens Healthineers and Bayer. These sponsors to the Society for Cardiovascular Magnetic Resonance provided financial support for the study but did not play a role in study design, data collection, analysis, interpretation, or manuscript drafting. Dr. Antiochos has received research funding from the Swiss National Science Foundation (grant P2LAP3_184037), the Novartis Foundation for Medical-Biological Research, the Bangerter-Rhyner Foundation, and the SICPA Foundation. Dr. Arai has research agreements with Siemens, Bayer, and Circle Cardiovascular Imaging. Dr. Bandettini is the principal investigator of one of the Bayer-sponsored GadaCAD2 (Gadavist-Enhanced Cardiac Magnetic Resonance Imaging to Detect Coronary Artery Disease) sites. Dr. Patel has received a research grant from and served on the Speakers Bureau of Astellas. Dr. Schulz-Menger has received research agreements with Siemens; and serves on the Advisory Board of Bayer. Dr. Stuber has received nonmonetary research support form Siemens Healthineers. Drs. Raman and Simonetti both receive institutional research support from Siemens. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. The SPINS registry was funded by the Society for Cardiovascular Magnetic Resonance, using a research grant jointly sponsored by Siemens Healthineers and Bayer. These sponsors to the Society for Cardiovascular Magnetic Resonance provided financial support for the study but did not play a role in study design, data collection, analysis, interpretation, or manuscript drafting. Dr. Antiochos has received research funding from the Swiss National Science Foundation (grant P2LAP3_184037), the Novartis Foundation for Medical-Biological Research, the Bangerter-Rhyner Foundation, and the SICPA Foundation. Dr. Arai has research agreements with Siemens, Bayer, and Circle Cardiovascular Imaging. Dr. Bandettini is the principal investigator of one of the Bayer-sponsored GadaCAD2 (Gadavist-Enhanced Cardiac Magnetic Resonance Imaging to Detect Coronary Artery Disease) sites. Dr. Patel has received a research grant from and served on the Speakers Bureau of Astellas. Dr. Schulz-Menger has research agreements with Siemens; and serves on the Advisory Board of Bayer. Dr. Stuber has received nonmonetary research support form Siemens Healthineers. Drs. Raman and Simonetti both receive institutional research support from Siemens. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Financiadores	Número del financiador
Advisory Board of Bayer
Circle Cardiovascular Imaging
SICPA Foundation
Speakers Bureau of Astellas
National Heart, Lung, and Blood Institute (NHLBI)	K23HL132011
Bayer
Siemens USA
Novartis Foundation
Society for Cardiovascular Magnetic Resonance
Siemens Medical Solutions USA
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung	P2LAP3_184037
Gottfried und Julia Bangerter-Rhyner-Stiftung

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging
Cardiology and Cardiovascular Medicine

Acceder al documento

10.1016/j.jcmg.2020.05.034

Otros archivos y enlaces

Citar esto

Ge, Y., Antiochos, P., Steel, K., Bingham, S., Abdullah, S., Chen, Y. Y., Mikolich, J. R., Arai, A. E., Bandettini, W. P., Shanbhag, S. M., Patel, A. R., Farzaneh-Far, A., Heitner, J. F., Shenoy, C., Leung, S. W., Gonzalez, J. A., Shah, D. J., Raman, S. V., Ferrari, V. A., ... Kwong, R. Y. (2020). Prognostic Value of Stress CMR Perfusion Imaging in Patients With Reduced Left Ventricular Function. JACC: Cardiovascular Imaging, 13(10), 2132-2145. https://doi.org/10.1016/j.jcmg.2020.05.034

@article{074c918a2a4f43a9a59a624a317ccc3b,

title = "Prognostic Value of Stress CMR Perfusion Imaging in Patients With Reduced Left Ventricular Function",

abstract = "Objectives: The aim of this study was to investigate the prognostic value of stress cardiac magnetic resonance imaging (CMR) in patients with reduced left ventricular (LV) systolic function. Background: Patients with ischemic cardiomyopathy are at risk from both myocardial ischemia and heart failure. Invasive testing is often used as the first-line investigation, and there is limited evidence as to whether stress testing can effectively provide risk stratification. Methods: In this substudy of a multicenter registry from 13 U.S. centers, patients with reduced LV ejection fraction (<50\%), referred for stress CMR for suspected myocardial ischemia, were included. The primary outcome was cardiovascular death or nonfatal myocardial infarction. The secondary outcome was a composite of cardiovascular death, nonfatal myocardial infarction, hospitalization for unstable angina or congestive heart failure, and unplanned late coronary artery bypass graft surgery. Results: Among 582 patients (mean age 62 ± 12 years, 34\% women), 40\% had a history of congestive heart failure, and the median LV ejection fraction was 39\% (interquartile range: 28\% to 45\%). At median follow-up of 5.0 years, 97 patients had experienced the primary outcome, and 182 patients had experienced the secondary outcome. Patients with no CMR evidence of ischemia or late gadolinium enhancement (LGE) experienced an annual primary outcome event rate of 1.1\%. The presence of ischemia, LGE, or both was associated with higher event rates. In a multivariate model adjusted for clinical covariates, ischemia and LGE were independent predictors of the primary (hazard ratio [HR]: 2.63; 95\% confidence interval [CI]: 1.68 to 4.14; p < 0.001; and HR: 1.86; 95\% CI: 1.05 to 3.29; p = 0.03) and secondary (HR: 2.14; 95\% CI: 1.55 to 2.95; p < 0.001; and HR 1.70; 95\% CI: 1.16 to 2.49; p = 0.007) outcomes. The addition of ischemia and LGE led to improved model discrimination for the primary outcome (change in C statistic from 0.715 to 0.765; p = 0.02). The presence and extent of ischemia were associated with higher rates of use of downstream coronary angiography, revascularization, and cost of care spent on ischemia testing. Conclusions: Stress CMR was effective in risk-stratifying patients with reduced LV ejection fractions.",

keywords = "cardiomyopathy, prognosis, stress cardiac MRI",

author = "Yin Ge and Panagiotis Antiochos and Kevin Steel and Scott Bingham and Shuaib Abdullah and Chen, \{Yi Yun\} and Mikolich, \{J. Ronald\} and Arai, \{Andrew E.\} and Bandettini, \{W. Patricia\} and Shanbhag, \{Sujata M.\} and Patel, \{Amit R.\} and Afshin Farzaneh-Far and Heitner, \{John F.\} and Chetan Shenoy and Leung, \{Steve W.\} and Gonzalez, \{Jorge A.\} and Shah, \{Dipan J.\} and Raman, \{Subha V.\} and Ferrari, \{Victor A.\} and Jeanette Schulz-Menger and Matthias Stuber and Simonetti, \{Orlando P.\} and Kwong, \{Raymond Y.\}",

note = "Publisher Copyright: {\textcopyright} 2020 American College of Cardiology Foundation",

year = "2020",

month = oct,

doi = "10.1016/j.jcmg.2020.05.034",

language = "English",

volume = "13",

pages = "2132--2145",

number = "10",

}

Ge, Y, Antiochos, P, Steel, K, Bingham, S, Abdullah, S, Chen, YY, Mikolich, JR, Arai, AE, Bandettini, WP, Shanbhag, SM, Patel, AR, Farzaneh-Far, A, Heitner, JF, Shenoy, C, Leung, SW, Gonzalez, JA, Shah, DJ, Raman, SV, Ferrari, VA, Schulz-Menger, J, Stuber, M, Simonetti, OP & Kwong, RY 2020, 'Prognostic Value of Stress CMR Perfusion Imaging in Patients With Reduced Left Ventricular Function', JACC: Cardiovascular Imaging, vol. 13, n.º 10, pp. 2132-2145. https://doi.org/10.1016/j.jcmg.2020.05.034

TY - JOUR

T1 - Prognostic Value of Stress CMR Perfusion Imaging in Patients With Reduced Left Ventricular Function

AU - Ge, Yin

AU - Antiochos, Panagiotis

AU - Steel, Kevin

AU - Bingham, Scott

AU - Abdullah, Shuaib

AU - Chen, Yi Yun

AU - Mikolich, J. Ronald

AU - Arai, Andrew E.

AU - Bandettini, W. Patricia

AU - Shanbhag, Sujata M.

AU - Patel, Amit R.

AU - Farzaneh-Far, Afshin

AU - Heitner, John F.

AU - Shenoy, Chetan

AU - Leung, Steve W.

AU - Gonzalez, Jorge A.

AU - Shah, Dipan J.

AU - Raman, Subha V.

AU - Ferrari, Victor A.

AU - Schulz-Menger, Jeanette

AU - Stuber, Matthias

AU - Simonetti, Orlando P.

AU - Kwong, Raymond Y.

PY - 2020/10

Y1 - 2020/10

N2 - Objectives: The aim of this study was to investigate the prognostic value of stress cardiac magnetic resonance imaging (CMR) in patients with reduced left ventricular (LV) systolic function. Background: Patients with ischemic cardiomyopathy are at risk from both myocardial ischemia and heart failure. Invasive testing is often used as the first-line investigation, and there is limited evidence as to whether stress testing can effectively provide risk stratification. Methods: In this substudy of a multicenter registry from 13 U.S. centers, patients with reduced LV ejection fraction (<50%), referred for stress CMR for suspected myocardial ischemia, were included. The primary outcome was cardiovascular death or nonfatal myocardial infarction. The secondary outcome was a composite of cardiovascular death, nonfatal myocardial infarction, hospitalization for unstable angina or congestive heart failure, and unplanned late coronary artery bypass graft surgery. Results: Among 582 patients (mean age 62 ± 12 years, 34% women), 40% had a history of congestive heart failure, and the median LV ejection fraction was 39% (interquartile range: 28% to 45%). At median follow-up of 5.0 years, 97 patients had experienced the primary outcome, and 182 patients had experienced the secondary outcome. Patients with no CMR evidence of ischemia or late gadolinium enhancement (LGE) experienced an annual primary outcome event rate of 1.1%. The presence of ischemia, LGE, or both was associated with higher event rates. In a multivariate model adjusted for clinical covariates, ischemia and LGE were independent predictors of the primary (hazard ratio [HR]: 2.63; 95% confidence interval [CI]: 1.68 to 4.14; p < 0.001; and HR: 1.86; 95% CI: 1.05 to 3.29; p = 0.03) and secondary (HR: 2.14; 95% CI: 1.55 to 2.95; p < 0.001; and HR 1.70; 95% CI: 1.16 to 2.49; p = 0.007) outcomes. The addition of ischemia and LGE led to improved model discrimination for the primary outcome (change in C statistic from 0.715 to 0.765; p = 0.02). The presence and extent of ischemia were associated with higher rates of use of downstream coronary angiography, revascularization, and cost of care spent on ischemia testing. Conclusions: Stress CMR was effective in risk-stratifying patients with reduced LV ejection fractions.

AB - Objectives: The aim of this study was to investigate the prognostic value of stress cardiac magnetic resonance imaging (CMR) in patients with reduced left ventricular (LV) systolic function. Background: Patients with ischemic cardiomyopathy are at risk from both myocardial ischemia and heart failure. Invasive testing is often used as the first-line investigation, and there is limited evidence as to whether stress testing can effectively provide risk stratification. Methods: In this substudy of a multicenter registry from 13 U.S. centers, patients with reduced LV ejection fraction (<50%), referred for stress CMR for suspected myocardial ischemia, were included. The primary outcome was cardiovascular death or nonfatal myocardial infarction. The secondary outcome was a composite of cardiovascular death, nonfatal myocardial infarction, hospitalization for unstable angina or congestive heart failure, and unplanned late coronary artery bypass graft surgery. Results: Among 582 patients (mean age 62 ± 12 years, 34% women), 40% had a history of congestive heart failure, and the median LV ejection fraction was 39% (interquartile range: 28% to 45%). At median follow-up of 5.0 years, 97 patients had experienced the primary outcome, and 182 patients had experienced the secondary outcome. Patients with no CMR evidence of ischemia or late gadolinium enhancement (LGE) experienced an annual primary outcome event rate of 1.1%. The presence of ischemia, LGE, or both was associated with higher event rates. In a multivariate model adjusted for clinical covariates, ischemia and LGE were independent predictors of the primary (hazard ratio [HR]: 2.63; 95% confidence interval [CI]: 1.68 to 4.14; p < 0.001; and HR: 1.86; 95% CI: 1.05 to 3.29; p = 0.03) and secondary (HR: 2.14; 95% CI: 1.55 to 2.95; p < 0.001; and HR 1.70; 95% CI: 1.16 to 2.49; p = 0.007) outcomes. The addition of ischemia and LGE led to improved model discrimination for the primary outcome (change in C statistic from 0.715 to 0.765; p = 0.02). The presence and extent of ischemia were associated with higher rates of use of downstream coronary angiography, revascularization, and cost of care spent on ischemia testing. Conclusions: Stress CMR was effective in risk-stratifying patients with reduced LV ejection fractions.

KW - cardiomyopathy

KW - prognosis

KW - stress cardiac MRI

UR - https://www.scopus.com/pages/publications/85090014533

UR - https://www.scopus.com/pages/publications/85090014533#tab=citedBy

U2 - 10.1016/j.jcmg.2020.05.034

DO - 10.1016/j.jcmg.2020.05.034

M3 - Article

C2 - 32771575

AN - SCOPUS:85090014533

SN - 1936-878X

VL - 13

SP - 2132

EP - 2145

JO - JACC: Cardiovascular Imaging

JF - JACC: Cardiovascular Imaging

IS - 10

ER -

Prognostic Value of Stress CMR Perfusion Imaging in Patients With Reduced Left Ventricular Function

Resumen

Nota bibliográfica

Financiación

ASJC Scopus subject areas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto